Literature DB >> 23793461

Surgical resection and radiation therapy of desmoid tumours of the extremities: results of a supra-regional tumour centre.

Peter Michael Prodinger1, Hans Rechl, Matthias Keller, Hakan Pilge, Maya Salzmann, Ruediger von Eisenhart-Rothe, Boris Michael Holzapfel.   

Abstract

PURPOSE: Desmoid tumours of the extremity have a high recurrence rate. The purpose of this study was to analyse the outcome after resection of these tumours with special emphasis on recurrent disease and adjuvant therapeutic strategies.
METHODS: In this retrospective study we evaluated prognostic factors for recurrence-free survival after surgical treatment of desmoid tumours of the extremity in 27 patients with an average age of 41 years treated from 1997 to 2009. Adjuvant radiotherapy (50-60 Gy) was given in five cases with primary and in nine patients with recurrent disease. The average follow-up was 64 months.
RESULTS: The five-year recurrence-free survival in patients with primary disease was 33%. Patients with negative resection margins tended to have a better outcome than patients with positive resection margins, but the difference between both groups was not significant (56 vs 14%, p = 0.145). In patients with positive margins, adjuvant radiotherapy did not significantly improve recurrence-free survival (40 vs 14%, p = 0.523). Patients with local recurrence had a five-year further recurrence-free survival of 47%. In those patients further recurrence-free survival was significantly better after adjuvant radiation (89 vs 25%, p = 0.015). Two thirds of all patients suffered moderate or severe complications due to the treatment regimen.
CONCLUSIONS: Compared to desmoids of the trunk or the head and neck region, desmoids affecting the limbs show by far the worst outcome in terms of relapse or treatment-related morbidity. The importance of negative resection margins is still not clear. Particularly in recurrent desmoids adjuvant radiotherapy appears to reduce the further recurrence rate. Therefore, a general use of radiation should be considered for this high-risk group.

Entities:  

Mesh:

Year:  2013        PMID: 23793461      PMCID: PMC3779554          DOI: 10.1007/s00264-013-1942-1

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  24 in total

1.  The desmoid tumor. Not a benign disease.

Authors:  M C Posner; M H Shiu; J L Newsome; S I Hajdu; J J Gaynor; M F Brennan
Journal:  Arch Surg       Date:  1989-02

Review 2.  Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles.

Authors:  J J Nuyttens; P F Rust; C R Thomas; A T Turrisi
Journal:  Cancer       Date:  2000-04-01       Impact factor: 6.860

3.  Extremity and trunk desmoid tumors: a multifactorial analysis of outcome.

Authors:  N B Merchant; J J Lewis; J M Woodruff; D H Leung; M F Brennan
Journal:  Cancer       Date:  1999-11-15       Impact factor: 6.860

4.  Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution.

Authors:  A Gronchi; P G Casali; L Mariani; S Lo Vullo; M Colecchia; L Lozza; R Bertulli; M Fiore; P Olmi; M Santinami; J Rosai
Journal:  J Clin Oncol       Date:  2003-04-01       Impact factor: 44.544

5.  Local control of extra-abdominal desmoid tumors.

Authors:  D J Pritchard; A G Nascimento; I A Petersen
Journal:  J Bone Joint Surg Am       Date:  1996-06       Impact factor: 5.284

6.  The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors.

Authors:  B W Goy; S P Lee; F Eilber; F Dorey; J Eckardt; Y S Fu; G J Juillard; M T Selch
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-10-01       Impact factor: 7.038

7.  Treatment of aggressive fibromatosis: a retrospective study of 72 patients followed for 1-27 years.

Authors:  Annemette Sørensen; Johnny Keller; Ole S Nielsen; Olaf M Jensen
Journal:  Acta Orthop Scand       Date:  2002-04

8.  The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor.

Authors:  J J Reitamo; T M Scheinin; P Häyry
Journal:  Am J Surg       Date:  1986-02       Impact factor: 2.565

9.  Extra-abdominal desmoid tumors.

Authors:  M G Rock; D J Pritchard; H M Reiman; E H Soule; R C Brewster
Journal:  J Bone Joint Surg Am       Date:  1984-12       Impact factor: 5.284

Review 10.  The pharmacological treatment of aggressive fibromatosis: a systematic review.

Authors:  J Janinis; M Patriki; L Vini; G Aravantinos; J S Whelan
Journal:  Ann Oncol       Date:  2003-02       Impact factor: 32.976

View more
  9 in total

1.  Large desmoid-type fibromatosis of the shoulder girdle: operative approach selection and clinic outcome.

Authors:  Fan Tang; Li Min; Rui Yin; Wenli Zhang; Yong Zhou; Yi Luo; Rui Shi; Hong Duan; Chongqi Tu
Journal:  Int Orthop       Date:  2015-01-21       Impact factor: 3.075

Review 2.  The Landmark Series: Desmoid.

Authors:  Marco Fiore; Aimee Crago; Rebecca Gladdy; Bernd Kasper
Journal:  Ann Surg Oncol       Date:  2021-01-01       Impact factor: 5.344

3.  Prognostic factors for second recurrence after surgical resection of recurrent desmoid-type fibromatosis.

Authors:  Justin M M Cates
Journal:  Pathol Oncol Res       Date:  2015-04-29       Impact factor: 3.201

4.  Desmoid Fibromatosis Presenting as Deep Venous Thrombosis: A Case Report and Discussion.

Authors:  Lisa M Marks; Susan J Neuhaus
Journal:  Am J Case Rep       Date:  2016-12-20

5.  EXTRA-ABDOMINAL DESMOID TUMOR: ANALYSIS OF 23 CONSECUTIVE CASES IN A SINGLE INSTITUTION.

Authors:  Juan Pablo Zumárraga; Brian Guilherme Monteiro Marta Coimbra; Felipe Gonçalves Dos Santos; André Mathias Baptista; Marcelo Tomio Kohara; Olavo Pires de Camargo
Journal:  Acta Ortop Bras       Date:  2018       Impact factor: 0.513

6.  Four different treatment strategies in aggressive fibromatosis: A systematic review.

Authors:  Jojanneke M Seinen; Maarten G Niebling; Esther Bastiaannet; Betty Pras; Harald J Hoekstra
Journal:  Clin Transl Radiat Oncol       Date:  2018-03-06

7.  Development, Validation, and Visualization of A Web-Based Nomogram for Predicting the Recurrence-Free Survival Rate of Patients With Desmoid Tumors.

Authors:  Haotian Liu; Kai Huang; Tao Li; Tielong Yang; Zhichao Liao; Chao Zhang; Lijie Xiang; Yong Chen; Jilong Yang
Journal:  Front Oncol       Date:  2021-02-25       Impact factor: 6.244

8.  Factors Associated with Disease Stabilization of Desmoid-Type Fibromatosis.

Authors:  Yongsung Kim; Mamer S Rosario; Hwan Seong Cho; Ilkyu Han
Journal:  Clin Orthop Surg       Date:  2020-02-13

9.  Value of imaging findings in predicting post-operative recurrence of desmoid-type fibromatosis.

Authors:  Junyan Wang; Yijuan Huang; Yanbao Sun; Yuxi Ge; Minming Zhang
Journal:  Oncol Lett       Date:  2019-11-21       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.